{
    "SPADE_UN_14024": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_14024",
            "Peptide Name": "vif 145-159",
            "Source": "Synthetic construct(derived from HIV-1 Vif protein)",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "LQYLALAALITPKKI",
            "Sequence Length": 15,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.12480936]HIV-1:inhibit vif-vif binding.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "Vif proteins",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C80H138N18O19",
            "Mass": 1656.06,
            "PI": 9.7,
            "Net Charge": 2,
            "Hydrophobicity": 0.98,
            "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min",
            "Mechanism of action": "Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.",
            "Literature": [
                {
                    "Title": "Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.",
                    "Pubmed ID": "12480936",
                    "Reference": "J Biol Chem. 2003 Feb 21;278(8)6596-602.",
                    "Author": "Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=12480936"
                }
            ],
            "Frequent Amino Acids": "LAI",
            "Absent Amino Acids": "CDEFGHMNORSUVW",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 11,
            "Polar Residues": 8,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_14022",
                    "Similarity": 1.0,
                    "Sequence": "AGHNKVGSLQYLALA"
                },
                {
                    "SPADE_ID": "SPADE_UN_14023",
                    "Similarity": 1.0,
                    "Sequence": "KVGSLQYLALAALIT"
                },
                {
                    "SPADE_ID": "SPADE_UN_14025",
                    "Similarity": 1.0,
                    "Sequence": "ALAALITPKKIKPPL"
                }
            ]
        }
    }
}